Identification of MAEL as a Promoter for the Drug Resistance Model of iPSCs Derived from T-ALL

The authors investigated the mechanism underlying drug resistance in T cell acute lymphoblastic leukemia (T-ALL) using the T-ALL-derived iPSCs model.